This is not just another tool to image cancer. The probe is a two-for-one: detect cancer and distinguish one type from another. Together, they develop a cancer fingerprint.
Determining the presence of cancer, as well as its type and malignancy, is a stressful process for patients that can take up to two weeks to get a diagnosis. With a new bit of technology—a sugar-transporting biosensor—researchers at Michigan Technological University hope to reduce that timeframe down to minutes.
A collaborative team of chemists and engineers from Michigan Tech lays the groundwork for this vision in two new papers. In the Royal Society of Chemistry’s journal Chemical Communication (DOI: 10.1039/c7cc09809j), the team explains the basic science behind multicolor probes that enable targeting of a cancer-relevant fructose transporter, delving into the image-based detection of cancer cells. In the journal Biosensors (DOI: 10.3390/bios8020039), the team addresses applications for breast cancer detection and differentiating nonmalignant, pre-malignant and malignant cancer cells.
GLUT5 transports fructose and cancer loves sugar
Two Michigan Tech researchers collaborated on the studies. Marina Tanasova, assistant professor of chemistry, and Smitha Rao, assistant professor of biomedical engineering, turned a 10-minute office meeting into a two-year collaboration built on a tiny fluorescent probe that seeks out the fructose transporter named GLUT5.
Cells need carbohydrates; facilitative glucose transporters (GLUTs) bring nutrients in and out of cells. When metabolic swings kick in—say, from cancer development—the overall make-up of GLUTs change so that more or less GLUTs are active. Fructose transporters like GLUT5 are of particular interest because of the direct connection between fructose uptake and cancer development, which also changes as cancer progresses and becomes malignant.
In their Chemical Communications paper, Tanasova and Rao’s team report on the design and validation of the fluorescent probes, called ManCous, to observe GLUT5 activity in a cell. They document the multicolored fluorescence that distinguishes GLUT5-rich cells from those deficient in GLUT5. The follow up Biosensors paper provides a proof-of-principle use of these probes as tools to assess and compare GLUT5 and metabolic activity of different cell types, including normal cells and different cancer subtypes.
“We came closer to a basic screening of cells’ GLUT composition—one that both detects cancer and distinguishes type,” Tanasova says, adding that while the concept is elegant, developing the technology is not easy. “From basic science to application, there is a lot of transformation that has to happen.”
Engineering better cancer detection takes collaboration
By better understanding the science behind sugar transporters, the team is more equipped to build technology that captures an accurate and precise GLUT fingerprint of cancerous cells.
“This probe is like a Swiss army knife,” Rao says, explaining that cancer detection is not the only use for the probe. “The more we learn about cancer through these probes, the more opportunities we have to apply them—which means more chances to treat different cancers, hopefully cure them, and at least prevent their spread and maximize drug delivery.”
What makes the probe so versatile is its ability to not only seek out and highlight cancer cells, but also to reveal the metabolic nuances of different stages of cancer development. While cancer generally gobbles up fructose, the GLUT5 and metabolic activity of nonmalignant, pre-malignant and malignant breast cancer cells do vary, which is what Rao, Tanasova and their team explored in the Biosensors paper. They found that ManCou probes allow for parallel analysis and quantification of GLUT5 and metabolic activity of cells just after a 10-minute incubation period. The notable differences in fluorescence intensity observed between normal cells and cancer cells, as well as different cancer types, provide important points of differentiation between different cell types and make these probes promising tools for cancer detection and diagnostics.
The Latest on: Cancer fingerprint
via Google News
The Latest on: Cancer fingerprint
- Designer DNA Helps Treat Multiple Myeloma in Miceon January 20, 2021 at 10:50 pm
New study suggests launch of Phase I clinical trial to test a designer DNA agent- an antisense oligonucleotide that targets a gene called IRF4 in patients with multiple myeloma.
- Novel nanomaterial generates powerful beams for enhanced optical imagingon January 20, 2021 at 6:14 am
Using DNA as a scaffold, engineers create synthetic nanomaterial that could pave the way for rapid and more accurate diagnostic testing from a single molecule.
- Tiny structures generate powerful beams for enhanced optical imagingon January 20, 2021 at 5:58 am
Even the smallest molecule can tell a big story. For instance, observing a single molecule can throw light on underlying biological processes in the human body. In fact, molecular imaging ...
- GR couple denied legal rights to biological twins due to 'outdated' Michigan fertility lawson January 19, 2021 at 12:20 pm
A Grand Rapids couple that FOX 17 has featured several time over the past few years, is hoping to change Michigan’s fertility laws after two different judges in Kent County denied their parental ...
- 'Titan of Maryland,' Senate President Emeritus Mike Miller, has diedon January 18, 2021 at 11:09 am
Senate President Emeritus Mike Miller died Friday afternoon.In a statement, the Miller family said: "At 4:25 p.m. this afternoon, Maryland Senate President Emeritus Thomas V. Mike Miller Jr. passed ...
- An unusual mission in Afghanistan, and the troops who suffered to carry it outon January 15, 2021 at 10:00 am
Once fired at, U.S. troops could shoot back and kill the otherwise shadowy enemy. “Stir the pot. Shake it up. If necessary, take fire,” is the way an officer describes an average day in Afghanistan in ...
- Richard Ramirez and the Real American Horror Story Behind the Night Stalker Murderson January 14, 2021 at 1:00 am
Richard Ramirez, dubbed "the Night Stalker" during his rampage of terror, is the subject of a new Netflix documentary series—after already finding a place in the AHS stable of real monsters.
- Who killed JonBenet Ramsey? An investigator's dying wish keeps the search going with his familyon January 13, 2021 at 6:23 am
She is now tasked along with other members of Smit’s family with solving his last case as part of his dying wish -- that of 6-year-old JonBenét Ramsey. Watch the full story on "20/20" Friday at 9 p.m.
- mRNA vaccines could vanquish COVID-19 today, cancer tomorrowon January 13, 2021 at 12:00 am
It can tell our cells to make whatever protein we want. That includes the antigens of many other diseases besides COVID-19.
via Bing News